Anirban Maitra, Director of the Perlmutter Cancer Center, shared a post on X:
“The NIH has ended continuous submission. The new policy gives two extra calendar weeks from the submission deadline if you have a study section or SEP as a reviewer within 4 weeks before or after a regular deadline, or serve on an NIH advisory council.”
Other articles featuring Anirban Maitra on OncoDaily.